General Information of Drug Off-Target (DOT) (ID: OTW5WCX9)

DOT Name Coiled-coil domain-containing protein 54 (CCDC54)
Synonyms Testis development protein NYD-SP17
Gene Name CCDC54
Related Disease
Cervical cancer ( )
Cervical carcinoma ( )
Endometrial cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Carcinoma of esophagus ( )
Clear cell adenocarcinoma ( )
Epithelial ovarian cancer ( )
Esophageal squamous cell carcinoma ( )
Head-neck squamous cell carcinoma ( )
Malignant uterine tumour ( )
Myelodysplastic syndrome ( )
Neoplasm of esophagus ( )
Neoplasm of testis ( )
Non-small-cell lung cancer ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Pituitary tumor ( )
Plasma cell myeloma ( )
Severe combined immunodeficiency ( )
Testicular cancer ( )
Triple negative breast cancer ( )
Advanced cancer ( )
Endometrial carcinoma ( )
Esophageal cancer ( )
Lung cancer ( )
Lung carcinoma ( )
UniProt ID
CCD54_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MYTLHTKRVKAAARQMWTSNLSKVRQSLKNVYHKCKIRHQDSTGYPTVTSDDCNQDDDSY
DGKMNLPVVLQDVKTAQVELFSQMTDIVHMIPKVQEKTDLYQKQMEVLETRMNVNEDKQC
TTTKDILSMKEDIKALKKKVTELEIQNSCSTIHCLEILEGERGKEITELLYKLIQPATLK
NTLASTDMEISSAEPEKVPSYPKSTDHLEKKTISPQMKTLKKRNHQNASRSFEKAKPNIY
IYPDFSTWIKLTFVHGGKWTFFLSATKLEEFIQWLLSRPTILPEEPQVITQRYCPFTGPI
LSLTTICLSIFNNIYGFICSLKEEVTRL

Molecular Interaction Atlas (MIA) of This DOT

28 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cervical cancer DISFSHPF Definitive Biomarker [1]
Cervical carcinoma DIST4S00 Definitive Biomarker [1]
Endometrial cancer DISW0LMR Definitive Biomarker [1]
Breast cancer DIS7DPX1 Strong Altered Expression [2]
Breast carcinoma DIS2UE88 Strong Altered Expression [2]
Breast neoplasm DISNGJLM Strong Altered Expression [2]
Carcinoma of esophagus DISS6G4D Strong Altered Expression [3]
Clear cell adenocarcinoma DISYUGHZ Strong Altered Expression [4]
Epithelial ovarian cancer DIS56MH2 Strong Biomarker [5]
Esophageal squamous cell carcinoma DIS5N2GV Strong Altered Expression [3]
Head-neck squamous cell carcinoma DISF7P24 Strong Altered Expression [6]
Malignant uterine tumour DIS3QDT8 Strong Biomarker [7]
Myelodysplastic syndrome DISYHNUI Strong Altered Expression [8]
Neoplasm of esophagus DISOLKAQ Strong Altered Expression [3]
Neoplasm of testis DISK4XHT Strong Biomarker [9]
Non-small-cell lung cancer DIS5Y6R9 Strong Biomarker [6]
Ovarian cancer DISZJHAP Strong Biomarker [5]
Ovarian neoplasm DISEAFTY Strong Biomarker [5]
Pituitary tumor DISN67JD Strong Biomarker [10]
Plasma cell myeloma DIS0DFZ0 Strong Biomarker [6]
Severe combined immunodeficiency DIS6MF4Q Strong Biomarker [11]
Testicular cancer DIS6HNYO Strong Biomarker [12]
Triple negative breast cancer DISAMG6N Strong Altered Expression [2]
Advanced cancer DISAT1Z9 moderate Altered Expression [4]
Endometrial carcinoma DISXR5CY moderate Altered Expression [7]
Esophageal cancer DISGB2VN Limited Altered Expression [2]
Lung cancer DISCM4YA Limited Biomarker [13]
Lung carcinoma DISTR26C Limited Biomarker [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 28 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Coiled-coil domain-containing protein 54 (CCDC54). [14]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Coiled-coil domain-containing protein 54 (CCDC54). [15]
------------------------------------------------------------------------------------

References

1 Sperm protein 17 is highly expressed in endometrial and cervical cancers.BMC Cancer. 2010 Aug 16;10:429. doi: 10.1186/1471-2407-10-429.
2 Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.Oncotarget. 2017 Aug 10;8(43):74378-74390. doi: 10.18632/oncotarget.20102. eCollection 2017 Sep 26.
3 Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer.Int J Cancer. 2007 Apr 15;120(8):1739-47. doi: 10.1002/ijc.22463.
4 Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.BMC Cancer. 2018 Oct 11;18(1):970. doi: 10.1186/s12885-018-4880-x.
5 Development of a M cell-targeted microparticulate platform, BSK02? for oral immunization against the ovarian cancer antigen, sperm protein 17.J Biomed Mater Res B Appl Biomater. 2019 Jan;107(1):29-36. doi: 10.1002/jbm.b.34092. Epub 2018 Mar 4.
6 The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.Oncotarget. 2017 Oct 31;8(59):100280-100287. doi: 10.18632/oncotarget.22213. eCollection 2017 Nov 21.
7 In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer.Int J Mol Sci. 2016 Sep 9;17(9):1525. doi: 10.3390/ijms17091525.
8 Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.Am J Transl Res. 2017 Feb 15;9(2):454-465. eCollection 2017.
9 Cancer immunotherapy targeting Sp17: when should the laboratory findings be translated to the clinics?.Am J Hematol. 2005 Sep;80(1):6-11. doi: 10.1002/ajh.20415.
10 Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Oncotarget. 2015 Feb 20;6(5):2812-26. doi: 10.18632/oncotarget.2802.
11 A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.J Immunol Methods. 2007 Apr 10;321(1-2):86-93. doi: 10.1016/j.jim.2007.01.010. Epub 2007 Feb 9.
12 Cancer-testis antigens as biomarkers for Merkel cell carcinoma: Pitfalls and opportunities.J Cutan Pathol. 2019 Oct;46(10):748-752. doi: 10.1111/cup.13528. Epub 2019 Jul 11.
13 Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells.Cell Immunol. 2015 Nov-Dec;298(1-2):18-24. doi: 10.1016/j.cellimm.2015.08.004. Epub 2015 Aug 18.
14 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.